Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRISTARDS trial - Thrombolysis Therapy for ARDS
2020-002913-16Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in acute respiratory distress syndrome (ARDS) comparing Intravenous alteplase with Control (standard of care) (2 arms). Primary endpoint: Time to clinical improvement or hospital discharge up to Day 28. Started Nov 2020; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on 2020-002913-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002913-16.